FI833047A - Mellanprodukter foer framstaellning av omeprazol - Google Patents

Mellanprodukter foer framstaellning av omeprazol Download PDF

Info

Publication number
FI833047A
FI833047A FI833047A FI833047A FI833047A FI 833047 A FI833047 A FI 833047A FI 833047 A FI833047 A FI 833047A FI 833047 A FI833047 A FI 833047A FI 833047 A FI833047 A FI 833047A
Authority
FI
Finland
Prior art keywords
omeprazol
foer framstaellning
mellanprodukter
mellanprodukter foer
sub
Prior art date
Application number
FI833047A
Other languages
English (en)
Other versions
FI833047A0 (fi
FI79701C (fi
FI79701B (fi
Inventor
Arne Elof Braendstroem
Bo Robert Lamm
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20347627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI833047(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI833047A0 publication Critical patent/FI833047A0/fi
Publication of FI833047A publication Critical patent/FI833047A/fi
Application granted granted Critical
Publication of FI79701B publication Critical patent/FI79701B/fi
Publication of FI79701C publication Critical patent/FI79701C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI833047A 1982-08-26 1983-08-25 Mellanprodukter foer framstaellning av omeprazol. FI79701C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8204879A SE8204879D0 (sv) 1982-08-26 1982-08-26 Novel chemical intermediates
SE8204879 1982-08-26

Publications (4)

Publication Number Publication Date
FI833047A0 FI833047A0 (fi) 1983-08-25
FI833047A true FI833047A (fi) 1984-02-27
FI79701B FI79701B (fi) 1989-10-31
FI79701C FI79701C (fi) 1990-02-12

Family

ID=20347627

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833047A FI79701C (fi) 1982-08-26 1983-08-25 Mellanprodukter foer framstaellning av omeprazol.

Country Status (28)

Country Link
US (2) US4544750A (fi)
EP (1) EP0103553B1 (fi)
JP (1) JPS5959662A (fi)
KR (1) KR880000091B1 (fi)
AT (1) ATE40884T1 (fi)
AU (1) AU560028B2 (fi)
CA (1) CA1234118A (fi)
CY (1) CY1328A (fi)
DD (1) DD233126A5 (fi)
DE (2) DE103553T1 (fi)
DK (1) DK381583A (fi)
ES (1) ES525122A0 (fi)
FI (1) FI79701C (fi)
GB (1) GB2126226B (fi)
GR (1) GR79374B (fi)
HK (1) HK19486A (fi)
HU (1) HU189738B (fi)
IE (1) IE55865B1 (fi)
IL (1) IL69175A (fi)
IS (1) IS1438B6 (fi)
MY (1) MY8600503A (fi)
NO (1) NO164093C (fi)
NZ (1) NZ204959A (fi)
OA (1) OA07498A (fi)
PH (1) PH17786A (fi)
PT (1) PT77249B (fi)
SE (1) SE8204879D0 (fi)
ZA (1) ZA835143B (fi)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
SE8504409D0 (sv) * 1985-09-24 1985-09-24 Haessle Ab Novel chemical intermediates
ES2053533T3 (es) * 1986-04-17 1994-08-01 Ici Plc Derivados de esteres de acido piridil-acrilico, un proceso para su preparacion y su uso como fungicidas.
US5221316A (en) * 1986-04-17 1993-06-22 Imperial Chemical Industries Plc Fungicides
US4920230A (en) * 1987-06-29 1990-04-24 Takeda Chemical Industries, Ltd. Method of producing nitrogen-containing heteroaromatic compounds having an alkoxy group
AT391693B (de) * 1988-11-15 1990-11-12 Cl Pharma Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2060541B1 (es) * 1993-02-26 1995-11-16 Vinas Lab Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
ES2097089B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Procedimiento para la preparacion de 2-hidroximetil-3,5-dimetil-4-metoxipiridina.
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
CA2204580A1 (en) * 1997-05-06 1998-11-06 Michel Zoghbi Synthesis of pharmaceutically useful pyridine derivatives
WO1999033807A2 (en) * 1997-12-24 1999-07-08 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives (intermediates) employing free radical substitution reactions to functionalize the 2-position of the pyridine
US6437139B1 (en) 1997-05-06 2002-08-20 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives
GB9717849D0 (en) * 1997-08-23 1997-10-29 Seal Sands Chemicals Limited Preparation of pyridene derivatives
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6197962B1 (en) 1998-01-26 2001-03-06 Kuraray Co., Ltd. Method for producing 2-sulfonylpyridine derivatives and method for producing 2-{[(2-pyridyl)methyl]thio}-1H-benzimidazole derivatives
US6350876B2 (en) 1998-01-26 2002-02-26 Kuraray Co., Ltd. 4-chloro-3,5-dimethyl-2-sulfonyl pyridines
US6303787B1 (en) 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
WO2000000474A1 (en) * 1998-06-26 2000-01-06 Russinsky Limited Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
GB9921578D0 (en) * 1999-09-13 1999-11-17 Cipla Limited Omeprazole synthesis
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
WO2003097606A1 (en) * 2000-07-28 2003-11-27 Herbex, Produtos Químicos, Sa New method for the preparation of the anti-ulcer compounds omeprazole, lansoprazole and pantoprazole
HUP0400438A3 (en) 2001-05-11 2007-08-28 Tibotec Pharm Ltd Broadspectrum 2-amino-benzoxazole-6-sulfonamides, their use as hiv protease inhibitor and pharmaceutical compositions containing them
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN100376574C (zh) * 2006-06-14 2008-03-26 浙江大学 泰妥拉唑的制备方法
EP2114919A2 (en) 2007-01-31 2009-11-11 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
CN101648912B (zh) * 2009-09-14 2012-07-04 南京第一农药集团有限公司 一种4-硝基-3,5-二甲基吡啶-n-氧化物的连续化制备方法
CN101648907B (zh) * 2009-09-14 2011-08-03 南京第一农药集团有限公司 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的纯化方法
CN102603620B (zh) * 2012-01-13 2014-10-29 江苏中邦制药有限公司 一种氯甲基吡啶或其吡啶衍生物盐酸盐的合成方法
MX2022002949A (es) 2019-09-24 2022-04-06 Prolacta Bioscience Inc Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
CN112142653B (zh) * 2020-10-22 2022-02-11 成都百泉生物医药科技有限公司 奥美拉唑中间体的制备方法
CN113307773A (zh) * 2021-06-17 2021-08-27 上海毕得医药科技股份有限公司 6-溴-3-甲氧基-1-苯基-1h-吲唑及其合成方法和应用
CN114805193B (zh) * 2022-04-19 2023-06-20 南京红太阳医药研究院有限公司 一种奥美拉唑中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2735851A (en) * 1956-02-21 Alkanolpykroine-n-oxides
US2663711A (en) * 1951-12-08 1953-12-22 Du Pont Process for the preparation of pyridine alcohols from pyridine n-oxides
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
ZA828136B (en) * 1981-11-05 1983-09-28 Byk Gulden Lomberg Chem Fab Substituted benzimidazoles,a process for their preparation,their use,and medicaments containing them
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
KR880000091B1 (ko) 1988-02-23
US4620008A (en) 1986-10-28
CA1234118A (en) 1988-03-15
US4544750A (en) 1985-10-01
HK19486A (en) 1986-03-27
IE55865B1 (en) 1991-01-30
GB2126226B (en) 1985-09-18
AU1710183A (en) 1984-03-01
IL69175A (en) 1987-01-30
ZA835143B (en) 1984-04-25
IL69175A0 (en) 1983-11-30
FI833047A0 (fi) 1983-08-25
MY8600503A (en) 1986-12-31
DE3379222D1 (en) 1989-03-30
ATE40884T1 (de) 1989-03-15
PH17786A (en) 1984-12-13
NZ204959A (en) 1985-12-13
IE831787L (en) 1984-02-26
FI79701C (fi) 1990-02-12
GB8322866D0 (en) 1983-09-28
CY1328A (en) 1986-06-27
GB2126226A (en) 1984-03-21
EP0103553B1 (en) 1989-02-22
IS2845A7 (is) 1984-02-27
JPS6353987B2 (fi) 1988-10-26
DE103553T1 (de) 1984-09-27
DD233126A5 (de) 1986-02-19
OA07498A (en) 1985-03-31
JPS5959662A (ja) 1984-04-05
HU189738B (en) 1986-07-28
NO164093C (no) 1990-08-29
AU560028B2 (en) 1987-03-26
DK381583A (da) 1984-02-27
PT77249B (en) 1986-07-14
EP0103553A1 (en) 1984-03-21
GR79374B (fi) 1984-10-22
ES8404993A1 (es) 1984-05-16
NO832794L (no) 1984-02-27
IS1438B6 (is) 1990-09-25
NO164093B (no) 1990-05-21
SE8204879D0 (sv) 1982-08-26
KR840005718A (ko) 1984-11-15
FI79701B (fi) 1989-10-31
PT77249A (en) 1983-09-01
DK381583D0 (da) 1983-08-19
ES525122A0 (es) 1984-05-16

Similar Documents

Publication Publication Date Title
FI833047A (fi) Mellanprodukter foer framstaellning av omeprazol
FI853625L (fi) Tetralinderivat, deras framstaellning och anvaendning.
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
FI812635L (fi) Piperidylidenderivat deras framstaellning och dessa innehaollande farmaceutiska blandningar
FI822281L (fi) Foerfarande foer framstaellning av pyrimidonderivat
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
FI921456A (fi) Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel
FI821141A0 (fi) 5,6-dihydro-11-alkylen-morfantridin-6-one, deras framstaellning och dessa innehaollande laekemedel
FI830939L (fi) Foerfarande foer framstaellning av nya derivat av indolizino(8,7-b)indol
GR1000471B (el) Μεθοδος παρασκευης κινολινοθειοαιθερων.
GR880100452A (el) Μυκητοκτονες συνθεσεις με βαση νικοτινικα παραγωγα,νεα νικοτινικα παραγωγα και η παρασκευη τους
JPS5283532A (en) Novel aromatic compounds
GR1000138B (el) Νεα παραγωγα ριβοφουρανουρονικου οξεος, μεθοδος δια την παρασευη αυτων και η χρησιμοποιησις αυτων.
FI832818A (fi) Foerfarande foer framstaellning av alfa- substituerade alkylarylketaler.
JPS5359673A (en) Pyridine derivatives and anticocciciosis agents containig the same as anactive constituent

Legal Events

Date Code Title Description
MA Patent expired

Owner name: AKTIEBOLAGET HAESSLE